156 related articles for article (PubMed ID: 21782616)
41. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages.
Yu H; Cook TJ; Sinko PJ
Pharm Res; 1997 Jun; 14(6):757-62. PubMed ID: 9210193
[TBL] [Abstract][Full Text] [Related]
42. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
[TBL] [Abstract][Full Text] [Related]
43. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
44. Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Bhatnagar PK; Takata JS; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Aug; 13(8):1213-8. PubMed ID: 8865315
[TBL] [Abstract][Full Text] [Related]
45. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
46. Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers.
Bertelsen KM; Greenblatt DJ; von Moltke LL
Biopharm Drug Dispos; 2006 Jul; 27(5):219-27. PubMed ID: 16552717
[TBL] [Abstract][Full Text] [Related]
47. Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes.
Matsumoto S; Saito H; Inui K
J Pharmacol Exp Ther; 1994 Aug; 270(2):498-504. PubMed ID: 8071843
[TBL] [Abstract][Full Text] [Related]
48. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
49. Transport of a Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Ala-His-Leu-Leu Across Human Intestinal Epithelial Caco-2 Cells.
Li Y; Zhao J; Liu X; Xia X; Wang Y; Zhou J
J Med Food; 2017 Mar; 20(3):243-250. PubMed ID: 28296590
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells.
Ishida K; Takaai M; Hashimoto Y
Biol Pharm Bull; 2006 Mar; 29(3):522-6. PubMed ID: 16508158
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers.
Takaai M; Suzuki H; Ishida K; Tahara K; Hashimoto Y
Biol Pharm Bull; 2007 Nov; 30(11):2167-72. PubMed ID: 17978494
[TBL] [Abstract][Full Text] [Related]
52. Permeability characteristics of polyamines across intestinal epithelium using the Caco-2 monolayer system: comparison between transepithelial flux and mitogen-stimulated uptake into epithelial cells.
Milovic V; Faust D; Turchanowa L; Stein J; Caspary WF
Nutrition; 2001 Jun; 17(6):462-6. PubMed ID: 11399404
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides.
Steensma A; Noteborn HP; Kuiper HA
Environ Toxicol Pharmacol; 2004 Apr; 16(3):131-9. PubMed ID: 21782699
[TBL] [Abstract][Full Text] [Related]
54. Active hexose transport across cultured human Caco-2 cells: characterisation and influence of culture conditions.
Riley SA; Warhurst G; Crowe PT; Turnberg LA
Biochim Biophys Acta; 1991 Jul; 1066(2):175-82. PubMed ID: 1906749
[TBL] [Abstract][Full Text] [Related]
55. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.
Inui K; Yamamoto M; Saito H
J Pharmacol Exp Ther; 1992 Apr; 261(1):195-201. PubMed ID: 1560365
[TBL] [Abstract][Full Text] [Related]
56. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
Kamm W; Raddatz P; Gante J; Kissel T
Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
[TBL] [Abstract][Full Text] [Related]
57. Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studies.
Zhou S; Feng X; Kestell P; Baguley BC; Paxton JW
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):87-97. PubMed ID: 15282097
[TBL] [Abstract][Full Text] [Related]
58. The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2.
Tian X; Yang X; Wang K; Yang X
Pharm Res; 2006 Aug; 23(8):1721-8. PubMed ID: 16832612
[TBL] [Abstract][Full Text] [Related]
59. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
